Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #145, December 2019
The U.S. Judicial Panel on Multidistrict Litigation has created a multidistrict litigation docket for claims asserted against Allergan for its Biocell textured breast implants, sending the lawsuits to the District of New Jersey.
A Washington federal judge has allowed the plaintiff in a spinal fusion device case to add three healthcare providers as defendants, ruling that failure to join them might result in separate and redundant actions.
A Louisiana federal judge has allowed an inadequate warning claim to proceed against the makers of blood coagulation test strips, ruling that the plaintiffs adequately alleged that their physician was not warned of the product’s possible malfunction.
A federal appellate panel has upheld an award of summary judgment to Medtronic Inc. in a hernia mesh action, finding the plaintiffs’ failure to present expert testimony doomed their case.
Non-Manufacturing Sellers May Use ‘Innocent Seller’ Provision as Affirmative Defense, Miss. High Court Rules
The Mississippi Supreme Court has ruled that the “innocent seller” provision of the state’s Products Liability Act provides an affirmative defense for non-manufacturing product sellers because it gives immunity to innocent sellers without placing a burden of proof on a plaintiff.
A Georgia legislative panel has recommended a series of tort reform measures, which include imposing a $250,000 cap on punitive damage awards in medical malpractice, product liability and personal injury actions.
A Pennsylvania federal judge has allowed strict liability claims to go forward against Coloplast Corp. in a pelvic mesh case, predicting that the state high court would recognize such claims against medical device manufacturers.
A New York federal judge has allowed strict liability design defect and failure to warn claims to proceed against Covidien in a lawsuit targeting its hernia mesh products, finding they were adequately pled in the plaintiffs’ amended complaint.
A Pennsylvania federal judge has remanded a multi-plaintiff Essure case for lack of federal jurisdiction, finding there is no actual dispute about the interpretation of federal law.
A federal appeals court has reinstated Racketeer Influenced and Corrupt Organization Act claims accusing the maker of Actos of failing to warn prescribing doctors of a link between type 2 diabetes drug Actos and bladder cancer.